Global Infertility Testing Market by Type (Female Infertility Testing, Male Infertility Testing), By Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), By Prescription Mode (Prescription-Based, Over The Counter (OTC) Based), By Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), By End User (Fertility Centers, Hospitals And Clinics, Research Institutes, Cryobanks), By Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa)– Industry Trends and Forecast to 2024
Get Free Sample Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-infertility-testing-market
Global Infertility Testing Market is expected to reach 22,421.79 million by 2024 from 13,347.10 million in 2016, at a CAGR of 6.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Major Players: Global Infertility Testing Market
The Merck KGaA is going to dominate the global infertility market followed by
- Procter & Gamble,
- Babystart Ltd,
- Biozhena Corporation,
- Quidel Corporation,
- Alere Inc.,
- Biomérieux SA,
- SPD Swiss Precision Diagnostics GmBH,
- Proctor & Gamble,
- SCSA Diagnostics Inc., among others.
GROWTH IN THE COLD CHAIN MARKET
Cold chain includes a series of refrigerated products, need of storage, distribution activities, logistics and other related equipment. Cold chain equipment is used in pharmaceutical sector, transportation, food sector, bio pharma, chemical sector and many more. For instance, pharmaceutical sector requires cold chain equipment for storage of vaccines, testing reagent, whole blood and refrigerated drugs. Logistic sector include transportation of horticulture, floriculture during distribution and supply. Food sector include processed foods, dairy and poultry consumption, instant and canned items. According to National Centre for Cold Chain Development (NCCD), in 2014, under Ministry of Agriculture & Farmers Welfare, support for cold chain was rationalized to revise the components and the cost norms along with a reduction of 5% in the subsidy rates.
SIGNIFICANT DECLINE IN FERTILITY RATES
Total fertility rates can be defined by the average number of children born to a woman who survives her reproductive years (aged 15-49). This fertility has dropped globally by about half since 1960. According to Eurostat, globally the total fertility rate has decreased from 4.45 in 1970 to around 2.50 in 2014. As the fertility rate is getting dropped worldwide, people get more aware of their health and visiting hospitals and clinics to get fertility testing done. Thus the decrease in fertility rate is also driving the growth of the market.
Market Segmentation: Global Infertility Testing Market
The global infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end user. The report provides data for 2015 to 2024, 2016 being the current year while 2017 to 2024 is the forecast period for the report.
On the basis of test kits are further sub divided into human Follicular Stimulating Hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits and others. In 2017, the Luteinizing Hormone (LH) Urine Test kits are expected to dominate the market with 41.6% market share
On the basis of prescription mode, the global infertility testing market is segmented into prescription-based and over the counter (OTC) based. In 2017, over the counter (OTC) based segment dominated the market with 83.21% market share.
On the basis of distribution channel, the global infertility testing market is classified into hospitals pharmacies, online pharmacies and pharmacies & drug stores. In 2017, the pharmacies & drug stores are expected to dominate the market with 49.8% market share.
On the basis of end user, the global infertility testing market is classified into fertility centers, hospitals and clinics, research institutes and cryobanks. In 2017, the Fertility Centers are expected to dominate the market with 40.5% market share.
Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.
Key Points: Global Infertility Testing Market
The Merck KGaA is going to dominate the global infertility market followed by Procter & Gamble, bioMérieux SA and other players operating in this market are include Babystart Ltd, Biozhena Corporation, Quidel Corporation, Alere Inc., SPD Swiss Precision Diagnostics GmBH, Proctor & Gamble, SCSA Diagnostics, Inc., among others.
Access Full Report: https://databridgemarketresearch.com/reports/global-infertility-testing-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar